These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas]. Richter J, Duchková H, Kubíková M. Cas Lek Cesk; 1975 Sep 26; 114(39):1201-3. PubMed ID: 1182748 [No Abstract] [Full Text] [Related]
28. [Experiences with immune BCG therapy of malignant melanoma]. Altmeyer P, Nödl F. Dtsch Med Wochenschr; 1978 Jul 28; 103(30):1214. PubMed ID: 668562 [No Abstract] [Full Text] [Related]
29. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule. Gutterman JU, Mavligit G, McBride C, Frei E, Hersh EM. Natl Cancer Inst Monogr; 1973 Dec 28; 39():205-12. PubMed ID: 4595319 [No Abstract] [Full Text] [Related]
30. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor. Jessup JM, Riggs CW, Hanna MG. Cancer Res; 1977 Aug 28; 37(8 Pt 1):2565-73. PubMed ID: 872084 [No Abstract] [Full Text] [Related]
31. Immunotherapy from malignant disease. Goodnight JE, Morton DL. Annu Rev Med; 1978 Aug 28; 29():231-83. PubMed ID: 348035 [No Abstract] [Full Text] [Related]
32. [Nonspecific immunostimulation and immunochemotherapy of melanomas]. Israël L. Rev Prat; 1975 Nov 28; 25(51):4063-4, 4067-8. PubMed ID: 1209147 [No Abstract] [Full Text] [Related]
33. [Immunotherapy of melanoma (proceedings)]. Bolund C. Lakartidningen; 1978 Dec 06; 75(49):4598. PubMed ID: 723350 [No Abstract] [Full Text] [Related]
34. Cancer immunotherapy. Richman SP, Gutterman JU, Hersh EM. Can Med Assoc J; 1979 Feb 03; 120(3):322-4, 329. PubMed ID: 371776 [Abstract] [Full Text] [Related]
35. [Medical therapy of malignant melanoma]. Mini E, Periti P. Ann Ital Chir; 1989 Feb 03; 60(4):257-63. PubMed ID: 2699710 [No Abstract] [Full Text] [Related]
36. Immunotherapy for human malignant melanoma. Kopf AW. South Med J; 1975 Apr 03; 68(4):495-503. PubMed ID: 1124416 [Abstract] [Full Text] [Related]
37. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma. Dandapat MC, Mohapatra SK, Patra SK. Indian J Cancer; 1985 Jun 03; 22(2):100-7. PubMed ID: 3842124 [No Abstract] [Full Text] [Related]
38. Immune response and non-specific immunotherapy in melanoma. El-Domeiri AA. Ann R Coll Surg Engl; 1978 Mar 03; 60(2):117-20. PubMed ID: 637492 [Abstract] [Full Text] [Related]
39. Immunotherapy of patients with cancer. Smith GV, Morse PA, Deraps GD, Raju S, Hardy JD. Surgery; 1973 Jul 03; 74(1):59-68. PubMed ID: 4715883 [No Abstract] [Full Text] [Related]
40. Surgical treatment of malignant melanoma. Rosenberg SA. Cancer Treat Rep; 1976 Feb 03; 60(2):159-63. PubMed ID: 769968 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]